Clinical Trial Update: RECOVER-ENERGIZE Platform Protocol [NA]

View source ↗

Summary

A platform protocol update for the RECOVER-ENERGIZE trial targeting long COVID; the study status is reported as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Duke University | Conditions: Long COVID, Long Covid19 | NA | Status: COMPLETED